Association and linkage studies of the 20q11.2 region (GRD-2 locus) with Graves' disease in the Tunisian population
- PMID: 17786592
- DOI: 10.1080/03014460701479580
Association and linkage studies of the 20q11.2 region (GRD-2 locus) with Graves' disease in the Tunisian population
Abstract
Objective: A genome-wide screen has shown linkage to the GRD-2 locus in Graves' disease (GD). Furthermore, a positional candidate gene maps to this locus; the CD40 gene has been reported to be associated and may predispose to the disease. The aim of this study was to replicate/reject the GRD-2 and to determine if the single nucleotide polymorphism (SNP) of the CD40 (CD40 C/T-1) confers susceptibility to GD.
Methods: The present study examined a dataset of 11 families with GD using 10 microsatellite markers and a case-control study consisting of 76 sporadic GD patients and 66 healthy subjects to determine the implication of the GRD-2. Both non-parametric linkage and association tests were performed. Genotyping of the CD40 C/T-1 was carried out using a polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP).
Results: The intrafamilial association and the case-control study showed no association between CD40 C/T-1 and GD. In addition, a high percentage of the C allele (96.9%) of CD40 SNP among control data was observed. The linkage analyses showed that the highest non-parametric LOD score was 1.67 at the D20S119 marker and the maximum attainable LOD score was 1.66. This result provides interesting evidence for linkage between GRD-2 and GD.
Conclusion: The CD40 gene seems to be not associated with GD in the Tunisian population, whereas the GRD-2 locus could harbour other candidate gene(s) to the genetic susceptibility of GD.
Similar articles
-
A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease.Thyroid. 2002 Dec;12(12):1129-35. doi: 10.1089/105072502321085234. Thyroid. 2002. PMID: 12593727
-
Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.Clin Endocrinol (Oxf). 2006 Sep;65(3):380-4. doi: 10.1111/j.1365-2265.2006.02608.x. Clin Endocrinol (Oxf). 2006. PMID: 16918960
-
Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study.Mol Genet Metab. 2004 Nov;83(3):264-70. doi: 10.1016/j.ymgme.2004.07.011. Mol Genet Metab. 2004. PMID: 15542398
-
Genetics of Graves' disease: the lost concept.Acta Med Indones. 2009 Jan;41(1):37-40. Acta Med Indones. 2009. PMID: 19258680 Review.
-
The genetic susceptibility to Graves' disease.Baillieres Clin Endocrinol Metab. 1997 Oct;11(3):431-50. doi: 10.1016/s0950-351x(97)80678-7. Baillieres Clin Endocrinol Metab. 1997. PMID: 9532333 Review.
Cited by
-
Association between the CD40 rs1883832 polymorphism and Graves' disease risk: a meta-analysis.EXCLI J. 2019 Jan 23;18:10-20. eCollection 2019. EXCLI J. 2019. PMID: 30956635 Free PMC article.
-
Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis.Oncotarget. 2017 Jun 28;8(60):102235-102243. doi: 10.18632/oncotarget.18704. eCollection 2017 Nov 24. Oncotarget. 2017. PMID: 29254239 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials